Avantor - AVTR Stock Forecast, Price & News

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Avantor in the last twelve months. There are currently 4 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AVTR shares.
View AVTR analyst ratings or view top-rated stocks.

14 brokers have issued 1-year price objectives for Avantor's shares. Their AVTR share price forecasts range from $24.00 to $40.00. On average, they expect the company's stock price to reach $29.33 in the next year. This suggests a possible upside of 39.5% from the stock's current price.
View analysts price targets for AVTR or view top-rated stocks among Wall Street analysts.

Avantor's stock was trading at $21.09 on January 1st, 2023. Since then, AVTR shares have decreased by 0.3% and is now trading at $21.02.
View the best growth stocks for 2023 here.

Avantor saw a increase in short interest in February. As of February 28th, there was short interest totaling 12,340,000 shares, an increase of 36.8% from the February 13th total of 9,020,000 shares. Based on an average trading volume of 6,390,000 shares, the short-interest ratio is presently 1.9 days.
View Avantor's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 27th 2023.
View our AVTR earnings forecast.

Avantor, Inc. (NYSE:AVTR) posted its quarterly earnings results on Friday, February, 3rd. The company reported $0.32 earnings per share for the quarter, topping analysts' consensus estimates of $0.30 by $0.02. The business earned $1.80 billion during the quarter, compared to the consensus estimate of $1.79 billion. Avantor had a net margin of 9.14% and a trailing twelve-month return on equity of 22.06%. The business's revenue was down 5.9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.36 earnings per share.

ETFs with the largest weight of Avantor (NYSE:AVTR) stock in their portfolio include Putnam BioRevolution ETF (SYNB), Harbor Health Care ETF (MEDI), First Trust Health Care AlphaDEX Fund (FXH), Nuveen ESG Mid-Cap Growth ETF (NUMG), First Trust Lunt U.S. Factor Rotation ETF (FCTR), Natixis Vaughan Nelson Mid Cap ETF (VNMC), Nuveen ESG Large-Cap Growth ETF (NULG) and BlackRock Future Health ETF (BMED).

Avantor updated its FY 2023 earnings guidance on Friday, February, 3rd. The company provided EPS guidance of $1.35-$1.45 for the period, compared to the consensus earnings per share estimate of $1.40. The company issued revenue guidance of -.

Based on aggregate information from My MarketBeat watchlists, some companies that other Avantor investors own include Honeywell International (HON), Johnson & Johnson (JNJ), NVIDIA (NVDA), Procter & Gamble (PG), Raytheon Technologies (RTX), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Pfizer (PFE) and QUALCOMM (QCOM).

(AVTR) raised $3 billion in an initial public offering on Friday, May 17th 2019. The company issued 154,000,000 shares at a price of $18.00-$21.00 per share. Goldman Sachs, J.P. Morgan, BofA Merrill Lynch, Barclays and Jefferies acted as the underwriters for the IPO and Credit Suisse, Deutsche Bank Securities, Evercore ISI, Guggenheim Securities, Morgan Stanley, UBS Investment Bank, Citigroup, Cowen, Piper Jaffray, RBC Capital Markets, Baird, William Blair, Janney Montgomery Scott, KeyBanc Capital Markets, PJT Partners, Raymond James, Stephens, Stifel, SunTrust Robinson Humphrey, Wells Fargo Securities and Drexel Hamilton were co-managers.

Avantor trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVTR."

Avantor's stock is owned by a number of retail and institutional investors. Top institutional investors include T. Rowe Price Investment Management Inc. (11.32%), Price T Rowe Associates Inc. MD (5.77%), Boston Partners (2.65%), American Century Companies Inc. (2.02%), Parnassus Investments LLC (1.30%) and Geode Capital Management LLC (1.25%). Insiders that own company stock include Christi Shaw, Christophe Couturier, David D Petratis, Devashish Ohri, Frederic Vanderhaegen, Gerard Brophy, James Bramwell, Jo Natauri, Justin Miller, Michael Stubblefield, Michael Wondrasch, New Mountain Investments Iii,, Rajiv Gupta, Steven W Eck and Thomas A Szlosek.
View institutional ownership trends.

Shares of AVTR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AVTR stock can currently be purchased for approximately $21.02.

Avantor (NYSE:AVTR) has a market capitalization of $14.18 billion and generates $7.51 billion in revenue each year. The company earns $686.50 million in net income (profit) each year or $1.02 on an earnings per share basis.

The company employs 14,500 workers across the globe.

Avantor's mailing address is BUILDING ONE SUITE 200 100 MATSONFORD ROAD, RADNOR PA, 19087. The official website for the company is www.avantorsciences.com. The company can be reached via phone at (610) 386-1700 or via email at avantorir@avantorsciences.com.